These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 12229130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE, Matutes E, Catovsky D.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F, Benboubker L, Gardembas M, Coiffier B, Divine M, Sebban C, Blanc M, Abgrall JF, Lederlin P, Harousseau JL, Blaise AM, Grosbois B, Morice P, Ghandour C, Castaigne S.
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [Abstract] [Full Text] [Related]

  • 8. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A, Jinnai I, Mizuno H, Sakata T, Kusumoto S, Kayano H, Takeuchi H, Bessho M, Saito M, Katayama I.
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of hairy-cell leukemia: current views.
    Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A.
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pentostatin and purine analogs for indolent lymphoid malignancies.
    Ho AD, Hensel M.
    Future Oncol; 2006 Apr; 2(2):169-83. PubMed ID: 16563086
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD, Thaler J, Willemze R, Lauria F, Derossi G, Kuse R, Stryckmans P, Blanc CM, Cataldo F, McVie G.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [Abstract] [Full Text] [Related]

  • 17. Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD, Thaler J, Willemze R, Lauria F, Mandelli F, Stryckmans P, de Cataldo F, Baccarani M, Peetermans ME, de Witte T.
    Cancer Treat Rev; 1990 Sep; 17(2-3):213-5. PubMed ID: 2272036
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [Abstract] [Full Text] [Related]

  • 19. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
    Döhner H, Ho AD, Thaler J, Stryckmans P, Sonneveld P, de Witte T, Lechner K, Lauria F, Bödewadt-Radzun S, Suciu S.
    J Natl Cancer Inst; 1993 Apr 21; 85(8):658-62. PubMed ID: 8468724
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.